(561) 802-3060 info@mri-news.com

This study is now closed to enrollment. To view currently enrolling studies please go to our currently enrolling studies page. For information on additional studies that will open in the future, please visit our upcoming studies page.

Type 1 Diabetes Clinical Trial
You may qualify to participate in a clinical research study comparing the safety and effectiveness of an investigational form of insulin in reducing blood glucose levels in Type 1 diabetics. Qualified candidates must be: •  diagnosed with Type 1 Diabetes •  using injectable insulin to manage their diabetes There is no cost to participate in this clinical research study. Qualified participants will receive all study related examinations, lab tests and study medications at no cost. You may also be reimbursed for your time and travel.  Health Insurance is not required. For more information, call 561-802-3060, ext. 8036 or complete this form.

*We respect your privacy.  All information submitted in this form is transmitted over secure servers, and will be kept strictly confidential.  In response to your inquiry, your information will be added to our in-house database and you will be contacted by email and/or phone by a clinical study coordinator to discuss research opportunities available to you.


Metabolic Research Institute’s clinical trials are the fastest and safest ways to find treatments that work and improve people’s health. Whether it’s diabetes, high blood pressure, heart disease, high cholesterol, or a variety of other health issues, clinical research studies provide the medicine of tomorrow… today.

Metabolic Research Institute, Inc. (“MRI”), is a private Clinical Research Company located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401. Unless otherwise noted, all study-related appointments for qualified clinical participants in any MRI research trial will take place at this address.